Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera and to be marketed by STADA Recommendation from EMA's CHMP committee is based on a robust analytical, non-clinical and clinical data package comparing the biosimilar...
Hence then, the article about golimumab biosimilar gotenfia from stada and bio thera receives positive chmp opinion was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion )
Also on site :
- What’s known about the man charged with attempting to assassinate President Trump at the White House Correspondents’ Dinner
- European ‘propaganda’ using Russia as ‘external enemy’ to mask crises – Kremlin
- 9 Years Ago Today, a Hulu Series Based on a 1985 Dystopian Book Premiered — And It Changed Everything for Us!